Skip to search formSkip to main contentSkip to account menu

BN83495

Known as: Steroid Sulfatase Inhibitor BN 83495 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Structure–activity relationship studies were conducted on Irosustat (STX64, BN83495), the first steroid sulfatase (STS) inhibitor… 
2009
2009
Background: BN83495/STX64 is an irreversible steroid sulfatase (STS) inhibitor blocking the hydrolysis of sulfated estrone E1S… 
2008
2008
The past few years have seen an increase in the reported incidence of endometrial carcinoma, one of the most frequently diagnosed… 
2008
2008
Steroid sulphatase (STS) inhibitors have been developed primarily for the treatment of hormone-dependent breast cancer, but may… 
Review
2007
Review
2007
Inhibitors of steroid sulfatase are being developed as a novel therapy for hormone-dependent breast cancer in postmenopausal… 
2007
2007
SY25-01 Breast cancer remains a major cause of death in women in most Western countries. While estrogens have an important role…